PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Highlights the firm's ability to meet near-term obligations and cover interest expenses. For conservative value investors, strong liquidity and coverage metrics are critical to avoid distress or forced dilution.
0.81
Current Ratio below 0.5x Medical - Pharmaceuticals median of 2.19. Jim Chanos might see a looming risk of liquidity crunch.
0.39
Quick Ratio below 0.5x Medical - Pharmaceuticals median of 1.73. Jim Chanos might see a liquidity gap if the firm cannot tap more credit swiftly.
0.33
Cash Ratio 0.5–0.75x Medical - Pharmaceuticals median of 0.62. Guy Spier might see partial vulnerability if obligations spike.
188.28
Interest coverage of 188.28 versus zero Medical - Pharmaceuticals median. Walter Schloss would verify if our debt service capacity provides advantages.
No Data
No Data available this quarter, please select a different quarter.